High Blood Pressure Study
Hypertension
Phase 3/4Active
Key Facts
About West Coast Research
West Coast Research LLC is a private, single-site clinical research site that has been operational since 2007. It functions as a service provider, enrolling patients into clinical trials sponsored by pharmaceutical companies and CROs, generating revenue through contracted research services. The company's model is site-focused rather than developing its own technology, positioning it within the broader clinical trial execution ecosystem. Its current activities appear centered on later-phase (likely Phase 3/4) patient recruitment for chronic conditions.
View full company profileTherapeutic Areas
Other Hypertension Drugs
| Drug | Company | Phase |
|---|---|---|
| Valsartan EP Impurity B | Synthink Research Chemicals | Reference Standard |
| Norliqva® (Amlodipine Oral Solution) | CMP Pharma | Approved |
| Renal & Hepatic Denervation for Hypertension | Metavention | Feasibility |
| MVD-1 (SANA) | Eolo Pharma | Discovery |
| Peregrine System Renal Denervation | Ablative Solutions | Phase 3 |
| Hypertension Program | Closed Loop Medicine | Development |
| GMRx2 | George Medicines | Phase 3 |
| Biobeat Cuff‑less ABPM Patch | Biobeat | Commercial |
| Zilebesiran (ALN-AGT) | Alnylam Pharmaceuticals | Phase 3 |
| DehydraTECH-CBD | Lexaria Bioscience | Human Clinical |